The Future of Telemedicine in Oncology

Presented by:
Lucy R. Langer
Search for other papers by Lucy R. Langer in
Current site
Google Scholar
PubMed
Close
 MD, MSHS
,
Amye J. Tevaarwerk
Search for other papers by Amye J. Tevaarwerk in
Current site
Google Scholar
PubMed
Close
 MD
, and
Robin Zon
Search for other papers by Robin Zon in
Current site
Google Scholar
PubMed
Close
 MD
Moderated by:
Travis Osterman
Search for other papers by Travis Osterman in
Current site
Google Scholar
PubMed
Close
 DO, MS
Restricted access

Abstract

The COVID-19 pandemic has led to a massive surge in the use of telemedicine services in oncology. However, although telemedicine usage is not as high as it was early in the pandemic, it is not as low as it was before the pandemic, either, indicating that patients have a desire to receive care when, where, and how they want. Most oncology providers agree that telemedicine is beneficial and here to stay, but barriers hinder equitable delivery, such as racial/ethnic affiliations, older age, residing in a rural area, and lower socioeconomic status. The momentum created by the pandemic can serve to show the benefits of telemedicine and solidify its place in oncology care. However, addressing these disparities—and increasing widespread access to broadband and educating both patients and providers on how to use these technologies—is paramount.

Disclosures: Dr. Langer has disclosed being employed by UnitedHealthcare. Dr. Tevaarwerk has disclosed no relevant financial relationships. Dr. Zon has disclosed having equity interest/stock options in AC3 HC Technology Com. RCM, Cytosorbents Corporation, Moderna, Oncolytics Biotech, Inc. Select Sector Health Care, and TG Therapeutics Equity; receiving honoraria from L‐NUTRA, Inc. and sanofi-aventis; and receiving consulting fees from and serving as a scientific advisor for New Century Health. Dr. Osterman has disclosed receiving consulting fees from and serving as a scientific advisor for AstraZeneca Pharmaceuticals LP, Biodesix, COTA Healthcare, eHealth, Flagship Biosciences, Inc., GenomOncology LLC, MDoutlook, and Outcomes Insights, Inc; receiving grant/research support from GE Healthcare and Microsoft; and having equity interest/stock options in Infostratix, LLC.

Correspondence: Travis Osterman, DO, MS, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN 37232. Email: travis.osterman@vumc.org
  • Collapse
  • Expand
  • 1.

    Institute of Medicine. Telemedicine: A Guide to Assessing Telecommunications in Health Care. Washington, DC: National Academies Press; 1996.

  • 2.

    ASCO PracticeNET. Accessed April 6, 2022. Available at: https://practice.asco.org/practice-support/practice-benchmarking/practicenet

    • PubMed
    • Export Citation
  • 3.

    Tevaarwerk AJ, Chandereng T, Osterman T, et al. Oncologist perspectives on telemedicine for patients with cancer: a National Comprehensive Cancer Network survey. JCO Oncol Pract 2021;17:e1318–1326.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Wehrle CJ, Lee SW, Devarakonda AK, et al. Patient and physician attitudes toward telemedicine in cancer clinics following the COVID-19 pandemic. JCO Clin Cancer Inform 2021;5:394400.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Loree JM, Dau H, Rebic N, et al. Virtual oncology appointments during the initial wave of the COVID-19 pandemic: an international survey of patient perspectives. Curr Oncol 2021;28:671677.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Triantafillou V, Layfield E, Prasad A, et al. Patient perceptions of head and neck ambulatory telemedicine visits: a qualitative study. Otolaryngol Head Neck Surg 2021;164:923931.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Zon RT, Kennedy EB, Adelson K, et al. Telehealth in oncology: ASCO standards and practice recommendations. JCO Oncol Pract 2021;17:546564.

  • 8.

    Thota R, Gill DM, Brant JL, et al. Telehealth is a sustainable population health strategy to lower costs and increase quality of health care in rural Utah. JCO Oncol Pract 2020;16:e557–562.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9.

    Kemp E, Trigg J, Beatty L, et al. Health literacy, digital health literacy and the implementation of digital health technologies in cancer care: the need for a strategic approach. Health Promot J Austr 2021; 32(Suppl 1):104114.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10.

    Coronavirus Preparedness and Response Supplemental Appropriations Act, HR 6074, 116th Congress (2020). Pub L No. 116-123. Accessed April 6, 2022.

  • 11.

    Improving Rural Health and Telehealth Access, Executive Order 13941 of August 3, 2020. Fed Regist 2020;85:4788147883.

  • 12.

    ASCO position statement: telemedicine cross-state licensure. Accessed April 6, 2022. Available at: https://www.asco.org/sites/new-www.asco.org/files/content-files/advocacy-and-policy/documents/2021-ASCO-Telemedicine-Licensure.pdf

    • PubMed
    • Export Citation
  • 13.

    Lacktman NM, Acosta JN, Iacomini SJ, Levine SJ. 50-State survey of telehealth commercial insurance laws. Accessed February 9, 2021. Available at: https://www.foley.com/en/insights/publications/2021/02/50-state-telehealth-commercial-insurance-laws

    • PubMed
    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 1738 636 51
PDF Downloads 828 271 24
EPUB Downloads 0 0 0